- Home
- FBLA vs GNLX Comparison
FBLA vs GNLX Comparison
Compare FBLA & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBLA
- GNLX
- Stock Information
- Founded
- FBLA 1908
- GNLX 2001
- Country
- FBLA United States
- GNLX United States
- Employees
- FBLA N/A
- GNLX N/A
- Industry
- FBLA
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- FBLA
- GNLX Health Care
- Exchange
- FBLA NYSE
- GNLX Nasdaq
- Market Cap
- FBLA 227.1M
- GNLX 184.4M
- IPO Year
- FBLA N/A
- GNLX 2023
- Fundamental
- Price
- FBLA $11.24
- GNLX $2.60
- Analyst Decision
- FBLA
- GNLX Strong Buy
- Analyst Count
- FBLA 0
- GNLX 4
- Target Price
- FBLA N/A
- GNLX $18.25
- AVG Volume (30 Days)
- FBLA 79.6K
- GNLX 161.3K
- Earning Date
- FBLA 01-01-0001
- GNLX 03-28-2025
- Dividend Yield
- FBLA N/A
- GNLX N/A
- EPS Growth
- FBLA N/A
- GNLX N/A
- EPS
- FBLA N/A
- GNLX N/A
- Revenue
- FBLA $64,935,000.00
- GNLX $8,000.00
- Revenue This Year
- FBLA N/A
- GNLX N/A
- Revenue Next Year
- FBLA N/A
- GNLX N/A
- P/E Ratio
- FBLA N/A
- GNLX N/A
- Revenue Growth
- FBLA N/A
- GNLX N/A
- 52 Week Low
- FBLA $10.74
- GNLX $1.60
- 52 Week High
- FBLA $12.74
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- FBLA N/A
- GNLX 30.97
- Support Level
- FBLA N/A
- GNLX $3.03
- Resistance Level
- FBLA N/A
- GNLX $3.35
- Average True Range (ATR)
- FBLA 0.00
- GNLX 0.37
- MACD
- FBLA 0.00
- GNLX -0.12
- Stochastic Oscillator
- FBLA 0.00
- GNLX 4.92
About FBLA FB BANCORP INC
FB Bancorp Inc is a holding company. It operates through its subsidiary Fidelity Bank. Fidelity business consists primarily of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market areas. Its services also include residential construction loans, commercial real estate loans (which includes commercial mortgage, commercial construction and land development loans), commercial loans (which includes commercial and industrial, small business and other commercial loans not secured by real estate), home equity loans and lines of credit, and consumer loans.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.